People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mid-Atlantic BioTherapeutics, Inc. | — | Biotechnology | Series A | $5.9M | $23.3M | 2018 |
David Horn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Horn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Katz | 1 | 4 |
| David Jobes | 1 | 2 |
| Julian Chick | 1 | 1 |
| Michael Goldblatt | 1 | 1 |
| Jean Pierre Gagnon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.